Stocks and Investing Stocks and Investing
Thu, March 16, 2017

EXEL, MMC, VGR, AVA, VAR, BMI, Expected to Trade Lower After Bearish Insider Trading


Published on 2017-03-16 04:45:11 - WOPRAI
  Print publication without navigation


March 16, 2017 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. Exelixis Inc. (NASDAQ:EXEL), Marsh & Mclennan Companies Inc. (NYSE:MMC), Vector Group Ltd (NYSE:VGR), Avista Corporation (NYSE:AVA), Varian Medical Systems Inc. (NYSE:VAR), Badger Meter Inc. (NYSE:BMI) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

  Symbol  Company Name                     Insider Name                     Role     Shares      Insider Score  Avg 6 Month Return  # of Dec. 
  EXEL    Exelixis Inc.                    Cohen, Charles M                 D        10,000      92             -28.5%              3         
  MMC     Marsh & Mclennan Companies Inc.  Rapport, Robert J                O        7,011       76             -2.4%               18        
  VGR     Vector Group Ltd                 Lebow, Bennett S                 D        100,000     100            -10.4%              69        
  AVA     Avista Corporation               Norwood, Kelly O.                O        5,474       88             -4.8%               15        
  VAR     Varian Medical Systems Inc.      Kuo, John W                      GC       862         89             -4.2%               45        
  BMI     Badger Meter Inc.                Smiley, Beverly L P              O        3,884       90             -8.8%               15        
The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

Exelixis Inc. (NASDAQ:EXEL) - Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. The company s products include CABOMETYX for the treatment of patients with advanced renal cell carcinoma, who have received prior anti-angiogenic therapy; and COMETRIQ for the treatment of patients with progressive, metastatic medullary thyroid carcinoma. Its CABOMETYX and COMETRIQ are derived from cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors, which has shown clinical anti-tumor activity in approximately 20 forms of cancer and is the subject of a broad clinical development program. It also offers COTELLIC (cobimetinib), a selective inhibitor of MEK, in combination with vemurafenib for the treatment of patients with BRAF V600E or V600K mutation-positive advanced melanoma in the United States; and in combination with vemurafenib in other territories, including the European Union, Switzerland, Canada, Australia, and Brazil. Exelixis, Inc. has collaboration and license agreements with Ipsen Pharma SAS, Genentech, Inc., GlaxoSmithKline, Bristol-Myers Squibb Company, Sanofi, Merck, and Daiichi Sankyo Company Limited for the development and commercialization of various compounds and programs. The company was formerly known as Exelixis Pharmaceuticals, Inc. and changed its name to Exelixis, Inc. in February 2000. Exelixis, Inc. was founded in 1994 and is headquartered in South San Francisco, California..

Marsh & Mclennan Companies Inc. (NYSE:MMC) - Marsh & McLennan Companies, Inc., a professional services firm, provides advice and solutions in the areas of risk, strategy, and people worldwide. It operates through two segments, Risk and Insurance Services; and Consulting. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, risk control, and mitigation solutions, as well as insurance, reinsurance broking, catastrophe and financial modeling services, and related advisory services. This segment serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, retirement, talent, and investments consulting services and products; and specialized management, and economic and brand consulting services. This segment assists public and private sector employers in the design, management, and administration of employee health care programs; provides a range of strategic and compliance-related retirement services and solutions to corporate, governmental, and institutional clients; advises organizations on the engagement, management, and rewarding of employees; and offers investment consulting and other services to the sponsors of pension funds, foundations, endowments, other investors, and wealth management companies. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York..

Vector Group Ltd (NYSE:VGR) - Vector Group Ltd., through its subsidiaries, manufactures and sells cigarettes in the United States. It operates through Tobacco, E-Cigarettes, and Real Estate segments. The company produces cigarettes in 116 combinations under the EAGLE 20's, PYRAMID, GRAND PRIX, LIGGETT SELECT, and EVE brand names, as well as USA and various partner brands, and private label brands. It also sells electronic cigarettes. In addition, the company provides residential brokerage, relocation, and real estate sales and marketing services, as well as title and settlement services to real estate companies and financial institutions; manages cooperatives, condominiums, and apartments; acquires, owns, and invests in real estate properties; and engages in land development activities. Further, it operates elliman.com, which serves as a destination where consumers can search properties and access market information, as well as offers building and neighborhood guides, and other interactive content; and AskElliman.com that facilitates communication with consumers, providing them with access to information from real estate to mortgage financing, to specific neighborhoods. Vector Group Ltd. markets and sells its cigarettes to candy and tobacco distributors, as well as grocery, drug, and convenience store chains. The company was formerly known as Brooke Group Ltd. Vector Group Ltd. was founded in 1911 and is based in Miami, Florida..

Avista Corporation (NYSE:AVA) - Avista Corporation operates as an electric and natural gas utility company. It operates in two segments, Avista Utilities, and Alaska Electric Light and Power Company. The Avista Utilities segment generates, transmits, and distributes electricity, as well as distributes natural gas in eastern Washington, northern Idaho, northeastern and southwestern Oregon, and Montana. This segment also engages in wholesale purchase and sales of electricity and natural gas. It owns hydroelectric, thermal, and wind generation facilities with a total capacity of 1,862 megawatts (MW). As of December 31, 2016, this segment supplied retail electric services to 377,000 customers and retail natural gas services to 340,000 customers. The Alaska Electric Light and Power Company segment owns and operates electric generation, transmission, and distribution facilities located in Juneau, Alaska. As of December 31, 2016, it operated five hydroelectric generation facilities with 102.7 MW of hydroelectric generation capacity; and had 107.5 MW of diesel generating capacity. This segment served approximately 17,000 customers, including city, state, and federal governmental entities located in Juneau, as well as a mine located in the Juneau area. The company also engages in the sheet metal fabrication of electronic enclosures, parts, and systems for the computer, construction, telecom, renewable energy, and medical industries; and investment of commercial and retail office space, as well as emerging technology venture capital funds. Avista Corporation was founded in 1889 and is headquartered in Spokane, Washington..

Varian Medical Systems Inc. (NYSE:VAR) - Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Imaging Components. The Oncology Systems segment provides hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy. Its products include linear accelerators, brachytherapy afterloaders, treatment simulation, verification equipment, and accessories; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians offices, oncology practices, radiotherapy centers, and cancer care clinics. The Imaging Components segment offers X-ray imaging components for use in radiographic or fluoroscopic imaging, mammography, special procedures, computed tomography, computer aided diagnostics, and industrial applications. It also provides Linatron X-ray accelerators, imaging processing software, and image detection products for security and inspection purposes. This segment serves original equipment manufacturers, independent service companies, and end-users. In addition, the company offers products and systems for delivering proton therapy; and develops technologies in the areas of digital X-ray imaging, volumetric and functional imaging, and improved X-ray sources. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California..

Badger Meter Inc. (NYSE:BMI) - Badger Meter, Inc. provides flow measurement, control, and communication solutions worldwide. It offers mechanical and electronic water meters, and related technologies and services to municipal water utilities; and meters and valves to measure and control materials flowing through a pipe or pipeline, including water, air, steam, oil, and other liquids and gases, as well as for use in water/wastewater, heating, ventilating and air conditioning, oil and gas, chemical and petrochemical, test and measurement, automotive aftermarket, and the concrete construction process industries. The company provides flow instrumentation technologies to original equipment manufacturers as the primary flow measurement device within a product or system; ORION Migratable for mobile meter reading; ORION Fixed Network for traditional fixed network applications; and ORION Cellular for infrastructure-free meter reading. It also serves municipalities, and commercial and industrial customers. The company sells its products through employees, resellers, and representatives. Badger Meter, Inc. was founded in 1905 and is headquartered in Milwaukee, Wisconsin..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources